Performance of European Member States in biotechnology
Sibylle Hinze and
Iciar Dominguez Lacasa ()
Science and Public Policy, 2004, vol. 31, issue 5, 344-358
Despite an increasing policy interest in biotechnology in Europe, there is a lack of internationally comparable data on national performance in biotechnology. This paper presents a performance analysis of 14 Member States using science technology and economic indicators. A strong relationship between scientific and commercial performance was found. Four performance clusters were identified: the best-performing countries Denmark, Sweden and Finland; the second-best performers The Netherlands, the United Kingdom, Belgium and Germany; cluster three with Austria, France and Ireland, performing below the European median performance value, and the Mediterranean countries Italy, Spain, Portugal and Greece performing weakly as measured by all indicators. Copyright , Beech Tree Publishing.
References: Add references at CitEc
Citations: View citations in EconPapers (3) Track citations by RSS feed
Downloads: (external link)
Access to full text is restricted to subscribers.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:oup:scippl:v:31:y:2004:i:5:p:344-358
Access Statistics for this article
Science and Public Policy is currently edited by Sybille Hinze, Jeong-Dong Lee and Nicholas Vonortas
More articles in Science and Public Policy from Oxford University Press
Bibliographic data for series maintained by Oxford University Press ().